In October, 2017, I received an email from Jim,* one of the three trial participants I interviewed in 2015. “Finally, they published a report!” Jim wrote.
Limitações da psiquiatria biomédica Controvérsia entre psiquiatras farmacológicos e reforma psiquiátrica Psiquiatria não comercial e íntegra Suporte para desmame de drogas psiquiátricas Concepções psicossociais Gerenciamento de benefícios/riscos dos psicoativos Acessibilidade para Deficiência psicossocial Psiquiatria com senso crítico Temas em Saúde Mental Prevenção quaternária Consumo informado Decisão compartilhada Autonomia "Movimento" de ex-usuários Alta psiquiátrica Justiça epistêmica
Menu
▼
domingo, 14 de janeiro de 2018
Brain Implants: Spinning the Trial Results to Protect the Product
https://www.madinamerica.com/2018/01/brain-implants-spinning-trial-results-protect-product/
Brain Implants: Spinning the Trial Results to Protect the Product
Two years ago, I wrote an article for MIA
about an experimental clinical trial called The Broaden Trial. It was,
and perhaps still remains, the largest clinical trial to investigate the
efficacy of deep brain stimulation for depression. The trial had been
terminated in 2013, due to a low 17% success rate among at least 75
patients that received the controversial brain implant. But the public
was given no additional details from the sponsor about the trial’s
protocols, or the outcome of at least 128 people that had enrolled in
this risky experimental study.
In October, 2017, I received an email from Jim,* one of the three trial participants I interviewed in 2015. “Finally, they published a report!” Jim wrote.
In October, 2017, I received an email from Jim,* one of the three trial participants I interviewed in 2015. “Finally, they published a report!” Jim wrote.
Nenhum comentário:
Postar um comentário